Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,981 | 13,893 | 17,638 | 18,717 | 22,228 |
| Marketable Securities | 26,546 | 26,513 | 27,106 | 29,305 | 30,227 |
| TOTAL | $37,457 | $41,454 | $45,055 | $48,673 | $53,479 |
| Non-Current Assets | |||||
| PPE Net | 231 | 244 | 249 | 259 | 178 |
| Other Non-Current Assets | 9 | 9 | 9 | 9 | 9 |
| TOTAL | $240 | $253 | $258 | $267 | $187 |
| Total Assets | $37,697 | $41,707 | $45,313 | $48,941 | $53,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 918 | 933 | 1,055 | 707 | 1,252 |
| Accrued Expenses | 988 | 1,161 | 940 | 1,598 | 1,412 |
| TOTAL | $1,906 | $2,095 | $1,996 | $2,306 | $2,664 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 696 | 303 | 414 | 310 | 466 |
| TOTAL | $696 | $303 | $414 | $310 | $466 |
| Total Liabilities | $2,601 | $2,398 | $2,410 | $2,616 | $3,129 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,786 | 82,972 | 82,871 | 82,871 | 82,871 |
| Common Shares | 83 | 83 | 83 | 83 | 83 |
| Retained earnings | -113,115 | -108,148 | -103,985 | -100,031 | -95,462 |
| TOTAL | $35,096 | $39,309 | $42,903 | $46,325 | $50,537 |
| Total Liabilities And Equity | $37,697 | $41,707 | $45,313 | $48,941 | $53,666 |